• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[罕见过敏原的变应原免疫疗法]

[Allergen immunotherapy for rare allergens].

作者信息

Mühlmeier Guido, Polk Marie-Luise, Tisch Matthias, Cuevas Mandy

机构信息

Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Deutschland.

Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus Klinik und Poliklinik für Hals‑, Nasen- und Ohrenheilkunde, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.

出版信息

HNO. 2024 Sep;72(9):626-632. doi: 10.1007/s00106-024-01469-0. Epub 2024 Apr 19.

DOI:10.1007/s00106-024-01469-0
PMID:38639764
Abstract

Among allergies to aeroallergens, approximately 20% are allotted to the so-called rare allergens. These include ash pollen, weed pollen, storage mites, molds, and animal allergens. The prevalences of allergies to these allergens are lower, but affected patients also suffer considerably from their "rare" allergy. Hence, these allergies should neither be overseen nor completely forgotten in daily practice. Especially mold, mite, and animal allergens often induce asthma, so that the significance of allergen-specific immunotherapy (AIT) should not be neglected in causal therapy. This work summarizes the current state of knowledge on the groups of rare aeroallergens in terms of characteristics, prevalences, and data on AIT. It is based on a systematic literature search performed in the MEDLINE (PubMed®) and Google Scholar databases. AIT preparations for rare allergens are classified as individual formulations and are not subject to the German Therapy Allergen Ordinance. Due to the low case numbers, the levels of evidence for these formulations are not as high as those for dust mites, grass, or birch pollen, but exhibit good efficacy in practical experience.

摘要

在对气传变应原的过敏中,约20%归因于所谓的罕见变应原。这些包括白蜡花粉、杂草花粉、仓储螨、霉菌和动物变应原。对这些变应原过敏的患病率较低,但受影响的患者也会因他们的“罕见”过敏而遭受相当大的痛苦。因此,在日常实践中,这些过敏既不应被忽视,也不应被完全遗忘。特别是霉菌、螨虫和动物变应原常诱发哮喘,因此在病因治疗中变应原特异性免疫疗法(AIT)的重要性不应被忽视。这项工作从特征、患病率和AIT数据方面总结了关于罕见气传变应原组的当前知识状态。它基于在MEDLINE(PubMed®)和谷歌学术数据库中进行的系统文献检索。针对罕见变应原的AIT制剂被归类为个体化制剂,不受德国治疗性变应原条例的约束。由于病例数较少,这些制剂的证据水平不如尘螨、草或桦树花粉的制剂高,但在实际经验中显示出良好的疗效。

相似文献

1
[Allergen immunotherapy for rare allergens].[罕见过敏原的变应原免疫疗法]
HNO. 2024 Sep;72(9):626-632. doi: 10.1007/s00106-024-01469-0. Epub 2024 Apr 19.
2
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).IgE介导的过敏性疾病中变应原特异性免疫治疗指南:德国变态反应学与临床免疫学会(DGAKI)、儿科变态反应与环境医学学会(GPA)、德国变态反应科医生医学协会(AeDA)、奥地利变态反应与免疫学会(ÖGAI)、瑞士变态反应与免疫学会(SGAI)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNO-KHC)、德国儿科学与青少年医学学会(DGKJ)、儿科肺病学会(GPP)、德国呼吸学会(DGP)、德国耳鼻喉外科医生协会(BV-HNO)、儿科医生与青年医生专业联合会(BVKJ)、肺科医生联邦协会(BDP)以及德国皮肤科医生协会(BVDD)的S2k指南
Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2.
3
[Immunotherapy of allergies: current status].[过敏症的免疫疗法:现状]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Nov;63(11):1341-1356. doi: 10.1007/s00103-020-03224-6. Epub 2020 Nov 2.
4
Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control.双过敏患者中使用“活性过敏原安慰剂”作为对照的随机免疫治疗试验。
Allergy. 2019 Aug;74(8):1480-1489. doi: 10.1111/all.13842. Epub 2019 May 28.
5
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.变应原免疫治疗:皮下免疫治疗和舌下免疫治疗变应性鼻炎/结膜炎和哮喘的疗效和安全性的证据。
J Allergy Clin Immunol Pract. 2024 Jun;12(6):1415-1427. doi: 10.1016/j.jaip.2024.04.034. Epub 2024 Apr 27.
6
Allergen extracts for immunotherapy: to mix or not to mix?用于免疫疗法的变应原提取物:混合还是不混合?
Expert Rev Clin Pharmacol. 2016;9(3):401-8. doi: 10.1586/17512433.2015.1131122. Epub 2016 Jan 8.
7
Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.对过敏性患者用梯牧草花粉提取物进行皮下免疫治疗诱导产生的重组和天然梯牧草花粉(rPhl p 1、2、5、6、7、11、12和nPhl p 4)特异性IgG4抗体的评估。
Int Arch Allergy Immunol. 2004 Sep;135(1):44-53. doi: 10.1159/000080042. Epub 2004 Jul 30.
8
Next generation immunotherapy for tree pollen allergies.下一代针对树花粉过敏的免疫疗法。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2402-2415. doi: 10.1080/21645515.2017.1367882.
9
Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets.氨甲酰化单体变应原疫苗作为尘螨和草花粉诱导的变应性鼻结膜炎舌下免疫治疗的一种治疗选择:对已发表试验的系统评价及使用Lais®片剂治疗的荟萃分析
Acta Dermatovenerol Alp Pannonica Adriat. 2010 Oct;19(3):3-10.
10
Recent advances in immunotherapy for allergic diseases.过敏性疾病免疫疗法的最新进展。
Recent Pat Inflamm Allergy Drug Discov. 2014 Jan;8(1):24-35. doi: 10.2174/1872213x07666131113111159.

本文引用的文献

1
Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.哮喘预防用变应原免疫治疗:随机和非随机对照研究的系统评价和荟萃分析。
Allergy. 2022 Jun;77(6):1719-1735. doi: 10.1111/all.15295. Epub 2022 Apr 2.
2
Immunological mechanisms involved in the human response to a dog dander allergoid.人类对犬皮屑类变应原反应中涉及的免疫机制。
Mol Immunol. 2022 May;145:88-96. doi: 10.1016/j.molimm.2022.02.020. Epub 2022 Mar 17.
3
Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial.
豚草舌下含片治疗儿童变应性鼻结膜炎的随机安慰剂对照试验的疗效与安全性
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2322-2331.e5. doi: 10.1016/j.jaip.2020.03.041. Epub 2020 Apr 15.
4
Allergic Rhinitis to Weed Pollen in Germany: Dominance by Plantain, Rising Prevalence, and Polysensitization Rates over 20 Years.德国杂草花粉过敏:车前草占主导地位,流行率上升,20 年来多敏率上升。
Int Arch Allergy Immunol. 2020;181(2):128-135. doi: 10.1159/000504297. Epub 2019 Dec 5.
5
Prevalence of allergic sensitization to storage mites in Northern Europe.北欧贮藏性螨致敏的流行情况。
Clin Exp Allergy. 2020 Mar;50(3):372-382. doi: 10.1111/cea.13536. Epub 2019 Dec 11.
6
Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study.皮下免疫治疗高剂量猫和狗提取物:真实研究。
J Investig Allergol Clin Immunol. 2020;30(3):169-174. doi: 10.18176/jiaci.0415. Epub 2019 May 27.
7
Reduction of active Fel d1 from cats using an antiFel d1 egg IgY antibody.利用抗 Fel d1 卵 IgY 抗体减少猫的活性 Fel d1。
Immun Inflamm Dis. 2019 Jun;7(2):68-73. doi: 10.1002/iid3.244. Epub 2019 Mar 9.
8
Component resolved analysis of ash pollen allergy in Bavaria.巴伐利亚州桦树花粉过敏的成分解析分析
Allergy Asthma Clin Immunol. 2018 Nov 8;14:76. doi: 10.1186/s13223-018-0291-4. eCollection 2018.
9
Development and characterization of an allergoid of cat dander for immunotherapy.用于免疫治疗的猫皮屑变应原样物质的研制与特性分析
Allergol Immunopathol (Madr). 2018 Sep-Oct;46(5):491-498. doi: 10.1016/j.aller.2017.12.003. Epub 2018 Jan 17.
10
Immunotherapy of mold allergy: A review.变应原免疫治疗:综述。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2397-2401. doi: 10.1080/21645515.2017.1314404. Epub 2017 May 8.